Free Trial

SurgePays (NASDAQ:SURG) Rating Increased to Hold at Wall Street Zen

SurgePays logo with Computer and Technology background

Key Points

  • Wall Street Zen has upgraded SurgePays (NASDAQ:SURG) from a "sell" to a "hold" rating, reflecting a change in analyst sentiment towards the stock.
  • Ascendiant Capital Markets also increased their price target on SurgePays from $8.75 to $9.00 while maintaining a "buy" rating.
  • Despite recent upgrades, SurgePays reported a quarterly loss, missing earnings expectations with a net margin of -133.85% and revenue significantly below projections.
  • Five stocks we like better than SurgePays.

SurgePays (NASDAQ:SURG - Get Free Report) was upgraded by analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a research note issued to investors on Saturday.

Separately, Ascendiant Capital Markets upped their price objective on SurgePays from $8.75 to $9.00 and gave the company a "buy" rating in a research note on Monday, June 16th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, SurgePays currently has an average rating of "Buy" and a consensus target price of $9.00.

Read Our Latest Report on SURG

SurgePays Stock Down 2.0%

SURG traded down $0.06 on Friday, reaching $2.74. The company's stock had a trading volume of 7,465 shares, compared to its average volume of 699,005. The stock has a market cap of $56.06 million, a price-to-earnings ratio of -1.10 and a beta of 0.43. SurgePays has a 1 year low of $1.05 and a 1 year high of $3.47. The company has a debt-to-equity ratio of 101.87, a current ratio of 1.11 and a quick ratio of 0.84. The business's 50 day moving average is $2.84 and its 200 day moving average is $2.49.

SurgePays (NASDAQ:SURG - Get Free Report) last issued its quarterly earnings results on Wednesday, August 13th. The medical equipment provider reported ($0.36) EPS for the quarter, missing analysts' consensus estimates of ($0.31) by ($0.05). SurgePays had a negative net margin of 133.85% and a negative return on equity of 333.87%. The business had revenue of $11.52 million during the quarter, compared to analysts' expectations of $16.14 million. SurgePays has set its FY 2025 guidance at EPS. As a group, research analysts forecast that SurgePays will post -1.66 EPS for the current fiscal year.

Institutional Trading of SurgePays

Institutional investors and hedge funds have recently made changes to their positions in the stock. Jane Street Group LLC acquired a new stake in shares of SurgePays during the 4th quarter worth approximately $54,000. Northern Trust Corp raised its position in shares of SurgePays by 67.4% during the 4th quarter. Northern Trust Corp now owns 63,269 shares of the medical equipment provider's stock worth $113,000 after purchasing an additional 25,467 shares during the period. Ethos Financial Group LLC acquired a new stake in SurgePays in the 1st quarter valued at approximately $57,000. Renaissance Technologies LLC increased its position in SurgePays by 43.6% in the 4th quarter. Renaissance Technologies LLC now owns 49,400 shares of the medical equipment provider's stock valued at $88,000 after acquiring an additional 15,000 shares during the period. Finally, Geode Capital Management LLC increased its position in SurgePays by 5.5% in the 4th quarter. Geode Capital Management LLC now owns 156,115 shares of the medical equipment provider's stock valued at $278,000 after acquiring an additional 8,097 shares during the period. 6.94% of the stock is currently owned by institutional investors and hedge funds.

About SurgePays

(Get Free Report)

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.

Further Reading

Should You Invest $1,000 in SurgePays Right Now?

Before you consider SurgePays, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SurgePays wasn't on the list.

While SurgePays currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.